Senior insider sale
Chief Discovery Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$2.69M
81.71K shares
What this filing means
KREITZER ANATOL plans to sell 81.71K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $2.69M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/17/2026ACC: 0001950047-26-007189
Officer· Chief Discovery Officer
Since Feb 2026
81.71K
Shares to sell
$2.69M
Approx. market value
17.17K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
7/1/2026
17.17KTotal acquired17.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Restricted Stock Units N/A | 17.17K | — |
| Total | 17.17K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
19.11K
Market value
$700.1K
7/15/2026
—Completed
Units to sell
45.42K
Market value
$1.35M
4/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
17.17K
Market value
$639.2K
7/17/2026
Total
Units
81.71K
Value
$2.69M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/15/2026 | 19.11K | $700.1K | — | Completed |
4/27/2026 | 45.42K | $1.35M | — | Completed |
| Planned — Approximate Date | ||||
7/17/2026 | 17.17K | $639.2K | NASDAQ | Planned |
| Total | 81.71K | $2.69M | ||